Cytotoxic Lung Endothelial Amyloids
细胞毒性肺内皮淀粉样蛋白
基本信息
- 批准号:9760953
- 负责人:
- 金额:$ 2.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AlveolarAmyloidAmyloid beta-ProteinAttenuatedAutophagocytosisBacteriaBlood CirculationCellsClinicalComplexCritical IllnessCyclic AMPCyclic GMPCyclic NucleotidesCytosolDataDiseaseEndothelial CellsEndotheliumFloodsGasesGenerationsHealthHematogenousHourHypoxemiaImpaired cognitionInfectionInnate Immune ResponseInnate Immune SystemIntoxicationLungLung infectionsMAP3K7 geneMediatingMicrotubulesMusNeurodegenerative DisordersNosocomial pneumoniaOrganOutcomePathogenicityPathologicPathway interactionsPatientsPermeabilityPhosphorylationPhosphotransferasesPrionsProcessProductionPseudomonas aeruginosaRecyclingReportingRoleSignal TransductionTestingTransforming Growth FactorsType III Secretion System PathwayWorkantimicrobialcytotoxicexoenzymeextracellularhyperphosphorylated tauinhibition of autophagynovelpathogenpreventrespiratorytau Proteinstau aggregation
项目摘要
PROJECT SUMMARY/ABSTRACT
Pulmonary endothelial barrier integrity is vital for efficient gas exchange and to prevent the hematogenous
dissemination of respiratory pathogens. Pseudomonas aeruginosa, a predominant agent of nosocomial
pneumonia, breaches the endothelial barrier by inducing junctional complex disruption leading to alveolar
flooding and hypoxemia. Here, we propose to study a previously unidentified, novel disease process defined by
the interaction of the common nosocomial pathogen, P. aeruginosa, with the host endothelium. P. aeruginosa
utilizes a Type III Secretion System (T3SS) to inject cytotoxic exoenzymes directly into the host cell. Exoenzyme
Y (ExoY), a T3SS effector expressed by ~90% of clinical P. aeruginosa strains, causes marked increases in
cytosolic cGMP, cUMP, and cAMP. The increase in cAMP facilitates the phosphorylation of an endothelial tau,
which dissociates from microtubules, followed by microtubule collapse, interendothelial gap formation, and
increased permeability. Hyperphosphorylated tau then coalesces into cytotoxic tau oligomers that are released
into the extracellular milieu. These cytotoxic tau oligomers are transmissibleand self-propagating amyloid prions.
The respective roles of cGMP and cUMP are currently unknown, although preliminary data establishes both a
temporal and spatial correlation between the increase in ExoY-generated cUMP and oligomeric tau release from
PMVECs. The cUMP signal in the bulk cytosol closely coincides with both the reduction of cytosolic tau and the
concomitant increase of extracellular tau. Thus, an ExoY-instigated increase in cUMP is implicated in the export
of cytotoxic tau. Furthermore, within the context of neurodegenerative disease, the degradation and recycling
pathway of autophagy is often pathologically constrained thereby preventing the breakdown of excess or
dysregulated amyloids. Following the inhibition of autophagic flux, dysregulated amyloids accumulate and
oligomerize. Clearance of nascent tau oligomers is often facilitated via exosomal and/or secretion mediated
export. Concordant with our observations, ExoY has recently been implicated in the suppression of the innate
immune response via the inhibition of transforming growth factor-β-activating kinase 1 (TAK1) which has also
been reported to obstruct autophagy. Taken together, ExoY suppression of TAK1 in PMVECs may contribute to
the inhibition of autophagy and the production of infection-induced tau prions. Therefore, this proposal tests the
hypothesis that ExoY-induced cUMP contributes to the suppression of autophagic flux thereby promoting the
generation and release of cytotoxic tau that transmissibly disrupts interendothelial junctions and promotes
perm eability.
.
项目概要/摘要
肺内皮屏障的完整性对于有效的气体交换和防止血行反应至关重要
呼吸道病原体的传播。铜绿假单胞菌,院内感染的主要病原体
肺炎,通过诱导连接复合体破坏而突破内皮屏障,导致肺泡
洪水和低氧血症。在这里,我们建议研究一种以前未识别的新型疾病过程,其定义为
常见的医院病原体铜绿假单胞菌与宿主内皮细胞的相互作用。铜绿假单胞菌
利用 III 型分泌系统 (T3SS) 将细胞毒性外切酶直接注射到宿主细胞中。胞外酶
Y (ExoY) 是一种 T3SS 效应子,约 90% 的临床铜绿假单胞菌菌株表达,可导致
胞质 cGMP、cUMP 和 cAMP。 cAMP 的增加促进内皮 tau 蛋白的磷酸化,
从微管解离,然后微管塌陷,内皮间隙形成,
增加渗透性。然后,过度磷酸化的 tau 蛋白结合成细胞毒性 tau 寡聚体并释放
进入细胞外环境。这些细胞毒性 tau 寡聚体是可传播且自我繁殖的淀粉样蛋白朊病毒。
尽管初步数据表明 cGMP 和 cUMP 各自的作用目前尚不清楚
ExoY 产生的 cUMP 增加与寡聚 tau 释放之间的时间和空间相关性
PMVEC。大量胞质中的 cUMP 信号与胞质 tau 的减少和
细胞外 tau 蛋白随之增加。因此,ExoY 引发的 cUMP 增加与出口有关
细胞毒性 tau 蛋白。此外,在神经退行性疾病的背景下,降解和回收
自噬途径通常受到病理学限制,从而防止过量或
淀粉样蛋白失调。自噬流受到抑制后,失调的淀粉样蛋白会积累并
低聚。新生 tau 寡聚体的清除通常通过外泌体和/或分泌介导来促进
出口。与我们的观察一致,ExoY 最近与先天性的抑制有关
通过抑制转化生长因子-β-激活激酶 1 (TAK1) 产生免疫反应,该激酶也具有
据报道可阻碍自噬。综上所述,PMVEC 中 TAK1 的 ExoY 抑制可能有助于
抑制自噬和感染诱导的 tau 朊病毒的产生。因此,本提案测试了
假设 ExoY 诱导的 cUMP 有助于抑制自噬流,从而促进
细胞毒性 tau 蛋白的产生和释放,可传播性破坏内皮间连接并促进
烫发能力。
。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sarah B. Voth其他文献
Sarah B. Voth的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sarah B. Voth', 18)}}的其他基金
相似国自然基金
基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
- 批准号:
- 批准年份:2020
- 资助金额:63 万元
- 项目类别:面上项目
基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
- 批准号:81870666
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
- 批准号:81601123
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
- 批准号:30971012
- 批准年份:2009
- 资助金额:35.0 万元
- 项目类别:面上项目
抗阿兹海默病Beta-Amyloid寡聚物单链可变区抗体的筛选及其动物试验
- 批准号:30570622
- 批准年份:2005
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Development of prevention of Alzheimer's disease using transgenic soybean expressing amyloid beta protein
使用表达β淀粉样蛋白的转基因大豆预防阿尔茨海默病的进展
- 批准号:
19K07989 - 财政年份:2019
- 资助金额:
$ 2.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Collaborative Research: Dynamics of surfactant - amyloid-beta protein interactions during self-assembly
合作研究:自组装过程中表面活性剂 - 淀粉样蛋白 - β 蛋白相互作用的动力学
- 批准号:
1802641 - 财政年份:2018
- 资助金额:
$ 2.9万 - 项目类别:
Standard Grant
Collaborative Research: Dynamics of surfactant - amyloid-beta protein interactions during self-assembly
合作研究:自组装过程中表面活性剂 - 淀粉样蛋白 - β 蛋白相互作用的动力学
- 批准号:
1802588 - 财政年份:2018
- 资助金额:
$ 2.9万 - 项目类别:
Standard Grant
Collaborative Research: Dynamics of surfactant - amyloid beta protein interactions during self-assembly
合作研究:自组装过程中表面活性剂-淀粉样β蛋白相互作用的动力学
- 批准号:
1802793 - 财政年份:2018
- 资助金额:
$ 2.9万 - 项目类别:
Standard Grant
Analysis of a new mechanism to specifically inhibit amyloid-beta protein production
特异性抑制β-淀粉样蛋白产生的新机制分析
- 批准号:
18K14883 - 财政年份:2018
- 资助金额:
$ 2.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Aggregation of amyloid-beta protein on size-controlled lipid nanoparticles
淀粉样β蛋白在尺寸控制的脂质纳米颗粒上的聚集
- 批准号:
16K18860 - 财政年份:2016
- 资助金额:
$ 2.9万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Structure and molecular interactions in aggregation of amyloid beta protein
β淀粉样蛋白聚集的结构和分子相互作用
- 批准号:
26860020 - 财政年份:2014
- 资助金额:
$ 2.9万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
A novel therapeutic strategy for Alzheimer's disease based on the promotion of clearance mechanism of amyloid beta protein
基于促进β淀粉样蛋白清除机制的阿尔茨海默病新治疗策略
- 批准号:
26670126 - 财政年份:2014
- 资助金额:
$ 2.9万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Amyloid Beta-Protein: Wild Type and Familial Mutant Assembly and Inhibition
β-淀粉样蛋白:野生型和家族突变体的组装和抑制
- 批准号:
8728102 - 财政年份:2013
- 资助金额:
$ 2.9万 - 项目类别:
Amyloid Beta-Protein: Wild Type and Familial Mutant Assembly and Inhibition
β-淀粉样蛋白:野生型和家族突变体的组装和抑制
- 批准号:
9110110 - 财政年份:2013
- 资助金额:
$ 2.9万 - 项目类别:














{{item.name}}会员




